greeksoup/ stock research

Sabra Health Care REIT (SBRA) Q3 FY2026 earnings: revenue $250 million, up 31.3% on the year

Sabra Health Care REIT, Inc. (SBRA) reported revenue of $250 million for Q3 FY2026, the quarter ended 30 September 2026, up 31.3% on the same quarter a year earlier. Net income was $29 million, up 26.9% on the year, and diluted earnings per share $0.11. The figures are the company's own, from the 10-Q it filed with the SEC on 2 November 2026.

Revenue
$250 million
+31.3% on the year · +5.8% on the quarter
Q4 FY2024Q3 FY2026
Operating margin
n/a
Q4 FY2024Q3 FY2026
Net income
$29 million
+26.9% on the year
Q4 FY2024Q3 FY2026
Diluted EPS
$0.11
+22.2% on the year
Q4 FY2024Q3 FY2026

this quarterthe same quarter a year earlierHover a bar for its figure.

Income statement (profit and loss)

$ millionQ3 FY2026Q2 FY2026Q3 FY2025On the quarterOn the yearLast 8 quarters
Revenue250236190+5.8%+31.3%
Interest expense29.229.828.9-2.1%+0.9%
Pre-tax income26.4-26.821.7+21.5%
Income tax0.10.70.4-89.5%-83.7%
Effective tax rate0.3%n/a2.0%
Net income28.6-25.222.5+26.9%
Net margin11.5%-10.7%11.9%
Diluted EPS$0.11-$0.10$0.09+22.2%
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionQ3 FY2026Q2 FY2026Q3 FY2025On the quarterOn the yearLast 8 quarters
Operating cash flow12985.8100.0+50.3%+29.0%
Cash from investing-17286.5-200
Cash from financing-152-57.4206
Depreciation and amortisation64.856.448.5+14.9%+33.5%
Share-based compensation3.94.12.9-4.1%+36.4%
Dividends paid76.675.771.9+1.3%+6.5%
Dividend per share$0.30$0.30$0.300.0%0.0%
Diluted shares, weighted260m252m244m+3.0%+6.7%
Shares outstanding at period end262m255m249m+2.5%+5.1%

Cash flow lines for the quarter; where the company files them year to date, the quarter is the difference between two filings.

Balance sheet

$ millionQ3 FY2026Q2 FY2026Q3 FY2025On the quarterOn the yearLast 8 quarters
Shareholders' equity2,8402,7512,825+3.2%+0.5%
Non-controlling interest1.61.72.0-5.4%-19.6%
Debt2,4362,6262,591-7.2%-6.0%
Other liabilities153134147+14.0%+4.1%
Total liabilities and equity5,4305,5135,565-1.5%-2.4%
Intangible assets87.283.059.8+5.1%+45.8%
Cash and equivalents36.2232201-84.4%-81.9%
Other assets5,3075,1985,304+2.1%+0.0%
Total assets5,4305,5135,565-1.5%-2.4%

Questions

What was Sabra Health Care REIT's revenue in Q3 FY2026?

Sabra Health Care REIT (SBRA) reported revenue of $250 million for Q3 FY2026, the quarter ended 30 September 2026, up 31.3% on the same quarter a year earlier.

How much did Sabra Health Care REIT earn in Q3 FY2026?

Net income for Q3 FY2026 was $29 million, up 26.9% on the year, and diluted earnings per share $0.11.

When did Sabra Health Care REIT report Q3 FY2026 results?

Sabra Health Care REIT filed its 10-Q for the quarter ended 30 September 2026 with the SEC on 2 November 2026.

Quarterly results, the last 20 quarters

Q4 FY2021 *Q1 FY2022Q2 FY2022Q3 FY2022Q4 FY2022 *Q1 FY2023Q2 FY2023Q3 FY2023Q4 FY2023 *Q1 FY2024Q2 FY2024Q3 FY2024Q4 FY2024 *Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025 *Q1 FY2026Q2 FY2026Q3 FY2026
Revenue136163156141165161161162163167176178182184189190212222236250
Interest expense25.725.025.527.127.928.528.328.227.928.429.329.528.127.127.528.928.928.429.829.2
Pre-tax income-10.643.719.6-45.13.5-7.922.2-14.018.427.324.329.347.240.565.221.726.039.4-26.826.4
Tax raten/a1%1%n/a4%n/a1%n/a3%2%2%-1%1%1%1%2%2%1%n/a0%
Net income-24.440.616.8-50.1-84.9-9.521.2-15.117.226.324.029.846.740.365.522.527.240.9-25.228.6
Net margin-18%25%11%-36%-51%-6%13%-9%10%16%14%17%26%22%35%12%13%18%-11%11%
Diluted EPS-$0.12$0.18$0.07-$0.22-$0.37-$0.04$0.09-$0.07$0.07$0.11$0.10$0.13$0.19$0.17$0.27$0.09$0.11$0.16-$0.10$0.11
Operating cash flow97.963.176.610867.668.370.383.278.752.880.197.780.080.381.0100.087.498.485.8129
Dividends paid68.669.369.369.369.369.469.469.469.469.469.570.371.071.471.471.974.875.775.776.6
Shares outstanding230m231m231m231m231m231m231m231m231m231m234m237m238m238m240m249m252m252m255m262m
Filing10-K10-Q10-Q10-Q10-K10-Q10-Q10-Q10-K10-Q10-Q10-Q10-K10-Q10-Q10-Q10-K10-Q10-Q10-Q
Each quarter as filed, linked to its filing.
Read more* The fourth quarter is the full year less the first three quarters, because the company files the year and not the quarter on its own. A fourth quarter's EPS, and its diluted share count where shown, are from the company's results press release for that quarter, checked against the company's filed figures or a second data source. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and the share count are as they are. Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Cash flow lines filed year to date are the difference between two filings. Shares outstanding are at the period end where the balance sheet tags them, otherwise the count on the filing's cover page. A derived fourth-quarter EPS is left blank when a split in the year makes the arithmetic meaningless.

10-Q for the period ended 30 September 2026, filed 2 November 2026: the filing.